MMSI Stock Fair Value Calculator – Research Firms Show Growing Support for Merit Medical Systems, on June 15, 2023
June 17, 2023
☀️Trending News
On June 15, 2023, the top research firms in the industry continued to show increasing support for Merit Medical Systems ($NASDAQ:MMSI), Inc. as its stock soared in popularity. Merit Medical Systems, Inc. is a global medical device company specializing in the design, manufacture and distribution of medical devices and technology. The company has also established itself as a leader in the field of interventional cardiology, endoscopy, radiology, orthopedics and vascular surgery. Merit is particularly well known for its innovative and cost-effective solutions for minimally invasive procedures such as angiography, angioplasty, ablation, and embolization.
The stock is up over 3% since the beginning of the year and this trend is expected to continue as the company continues to develop innovative and cost-effective solutions for healthcare providers across the globe. With the continued support of the top research firms, Merit Medical Systems, Inc. looks well positioned to lead the way in the medical device industry in the years to come. With its strong financial position and commitment to delivering quality products and services, Merit Medical Systems, Inc. is sure to continue its success.
Price History
On Friday of that week, the company’s stock opened at $83.1 and closed at $83.3, representing a 1.3% increase from the preceding day’s closing price of $82.2. This rise in share value was largely propelled by the growing optimism among investors and research firms. Analysts have forecasted a bright future for Merit Medical Systems, Inc., citing their extensive portfolio of medical device products and recent expansions into new markets. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for MMSI. More…
| Total Revenues | Net Income | Net Margin |
| 1.17k | 84.67 | 8.0% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for MMSI. More…
| Operations | Investing | Financing |
| 116.83 | -62.38 | -46.52 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for MMSI. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.68k | 512.45 | 20.4 |
Key Ratios Snapshot
Some of the financial key ratios for MMSI are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 5.5% | 40.3% | 8.6% |
| FCF Margin | ROE | ROA |
| 5.6% | 5.5% | 3.8% |
Analysis – MMSI Stock Fair Value Calculator
At GoodWhale, we have conducted an analysis of MERIT MEDICAL SYSTEMS’ fundamentals. Our proprietary Valuation Line has determined that the intrinsic value of a MERIT MEDICAL SYSTEMS share is around $66.2. Currently, the stock is trading at $83.3, which is an overvaluation of 25.9%. This means that investors are currently paying more than the intrinsic value of the stock as calculated by our Valuation Line. We advise investors to look further into this stock before making any decisions. More…
Peers
The company’s products are used in a variety of medical procedures, including cardiovascular, gastrointestinal, urological, and obstetrical/gynecological procedures. The company has a strong competitive position in the medical device market, with a leading market share in many of its product categories.
However, the company faces competition from a number of well-established competitors, including Medeon Biodesign Inc, Pixium Vision SA, and AngioDynamics Inc.
– Medeon Biodesign Inc ($TPEX:6499)
Medeon Biodesign Inc is a medical device company that develops and commercializes products for the treatment of cardiovascular diseases. The company has a market cap of 4.55B and a ROE of -6.27%. Medeon Biodesign Inc’s products are used in the treatment of coronary artery disease, heart failure, and other cardiovascular conditions. The company’s products are sold in over 30 countries worldwide.
– Pixium Vision SA ($OTCPK:PXMVF)
Pixium Vision SA is a French company that designs, develops, and markets bionic vision systems to enable patients who have lost their sight to regain some level of vision. The company’s products include the PRIMA bionic vision system, which consists of an implantable microstimulator and a wearable camera and glasses, and the IRIS II bionic vision system, which consists of an implantable microstimulator and a contact lens. Pixium Vision SA’s products are intended for use in patients with retinitis pigmentosa, macular degeneration, and other degenerative eye diseases.
– AngioDynamics Inc ($NASDAQ:ANGO)
AngioDynamics Inc is a medical device company that designs, manufactures, and sells products used by interventional physicians to treat vascular diseases. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc has a market cap of 549.46M as of 2022, a Return on Equity of -5.11%. The company’s products are used in a variety of procedures, including angioplasty, thrombectomy, ablation, and vascular access. AngioDynamics Inc’s products are sold in over 50 countries worldwide.
Summary
Investment analysts have been bullish on Merit Medical Systems, Inc. (MMS) since June 15, 2023. Research firms have noted the company’s consistent growth in revenue and earnings, its strong balance sheet, and its attractive dividend yield. MMS has been able to successfully develop and market high-quality medical products, and has continued to gain market share in recent years. Analysts believe that these factors make MMS an attractive investment opportunity for long-term investors.
In addition, analysts have noted that the company’s share price has increased significantly over the past year, indicating further confidence in the company’s prospects.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
